How would you treat a patient with widely metastatic clear cell RCC who has undergone craniotomy/resection of a single brain metastasis?
In the setting of recent craniotomy and a plan for SRS to the surgical cavity, which systemic therapy would you choose and when would you start it?
2 Answers
Mednet MemberInvited Expert
Medical Oncology · Cedars-Sinai Medical Center
Answered on
Initial therapy in the front line setting for a person with widel metastatic disease would include either sunitinib or pazopanib. I would not use IL2 in this setting because of the recent brain surgery. Clinical trials should also be considered,
Join for free or sign in to see the full answer
Mednet MemberInvited Expert
Medical Oncology · Vanderbilt-Ingram Cancer Center
Answered on
I agree with @Dr. First Last. Making sure surgical wounds are healed before starting TKI is important, otherwise you will end up holding drug and having wound healing issues.
Join for free or sign in to see the full answer